It was a pleasure to have co-organized the Cancer Cell Therapy Summit 2024 alongside the Champalimaud Foundation that brought together leading minds in the field! A huge thank you to Jason Bock for sharing insights on the innovative approach to patient-adjacent manufacturing. It was inspiring to learn how patient treatments can be delivered more efficiently in terms of time, quality, and cost.
Jason Bock recently spoke at the Champalimaud Foundation and CIMT's Cancer Cell Therapy Summit 2024 in beautiful Lisbon, Portugal. Over two days, we discussed ways to redefine the relationship between academic institutions, hospitals, and medical centers through patient-adjacent manufacturing. This regionalized model for potentially curative treatments is an efficient, cost-effective approach for modalities that begin and end with the patient. Thank you to Christoph Huber and Markus Maeurer for organizing an excellent event. #biotech #celltherapy #cellpharmacy #endcancer